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Dear Sir,
We would like to thanks Anele and colleagues for their valued comments regarding our recently published article [1] . We feel it is first of all important to acknowledge them as the authors of Anele CC et al. Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis. Color Dis. 2017;19(6):528-36 referenced in our article (reference 27) [2] .
We are thankful for Anele and colleagues for undertaking a re-analysis of their data excluding the study performed by Aronson et al. [3] . This was an important omission in the original study and we are glad they have acknowledged and corrected this, and we feel this also underlines the importance of access to this unpublished data from the paper by Aronson et al., in order to perform a robust meta-analysis. We also accept the point raised in their letter about two rectal metachronous colorectal cancer in the Stupart study [4] . We also appreciate that the results of our analyses are similar, however feels that the differences identified by this re-analysis are important to publish as more definitive result, better informing future studies.
With regard to the other points raised we agree that the statement 'In LS, segmental colectomy results in a significant increased risk of developing MCC' could be misleading, and should have included more context. We would disagree that there is little mention of complications and poorer functional outcomes. Despite not being the primary outcome of this study we feel we have addressed this in both the discussion and conclusion-indeed we have emphasised the need for an individualised approach to surgical decision making in Lynch Syndrome patients. As reported by other studies (including the study by Anele and colleagues) data on morbidity, bowel function and quality of life is often not reported making further subanalysis challenging. We have reported the results as relative risk, reflecting both included studies and similar systematic reviews and meta-analysis. The addition of number need to treat was considered for the analysis, however was problematic to calculate (using the baseline studies) and has not been included in similar systematic reviews and meta-analysis (including the study by Anele and colleagues) however would be a useful addition in future studies.
We agree with the final comments by Anele and colleagues that management decisions are highly personalised and need to consider a plethora of factors. However we feel that analyses such as this study provide valuable information and insight to both clinicians and patients allowing them to make a more informed choice.
